TORONTO, July 31, 2025 (GLOBE NEWSWIRE) -- Trisura Group Ltd. (“Trisura” or “Trisura Group”) (TSX: TSU), a leading specialty insurance provider, announces the timing of second quarter 2025 results release and earnings conference call. Trisura will release its second quarter 2025 results after market close on Thursday, August 7th, 2025. The company will host a conference call for analysts and investors on Friday, August 8th, 2025 at 9:00 a.m. ET. Conference call participants will be David Clare, President an ...

Diluted earnings per share (“EPS”) of $0.60Invested $51 million in water and wastewater utility infrastructure during the first half of 2025, or approximately 55% of the 2025 capital budgetConstructive outcome of the general base rate case in DelawareDeclared $0.34 common stock cash dividend ISELIN, N.J., July 31, 2025 (GLOBE NEWSWIRE) -- Middlesex Water Company (“Middlesex” or the “Company”) (NASDAQ: MSEX) today announced financial results for the second quarter ended June 30, 2025. “We appreciate the dedi ...

Core Insights - Sun Country Airlines reported a total revenue of $264 million for the second quarter of 2025, marking a 3.6% increase compared to the same period in 2024 [3][8] - The company achieved a GAAP diluted EPS of $0.12 and an adjusted diluted EPS of $0.14, reflecting significant year-over-year growth [2][4] - The airline has successfully integrated additional cargo aircraft into its operations, with expectations to have all 20 freighters in service by the end of the third quarter [2][5] Financial Performance - Total operating revenue for the second quarter was $263.6 million, up from $254.4 million in 2024, representing a 3.6% increase [3] - Operating income increased by 31.5% to $16.3 million, with a GAAP operating margin of 6.2% and an adjusted operating margin of 6.8% [3][4] - Net income for the quarter was approximately $6.6 million, a 263% increase from $1.8 million in the previous year [3][4] Cargo and Charter Operations - Cargo revenue surged by 36.8% to $35 million, driven by a 9.5% increase in cargo block hours and new contract rates with Amazon [9][5] - Charter revenue also saw a 6.4% increase, totaling $54 million, although it was slightly below the growth rate of charter block hours [8][9] Capacity and Demand - The company experienced a 3.9% decline in total available seat miles (ASMs) due to a strategic reduction in passenger service to accommodate cargo growth [2][7] - Scheduled service TRASM increased by 3.7%, indicating robust demand despite a 6.2% decrease in scheduled service ASMs [2][8] Cost Structure - CASM increased by 6.3%, while adjusted CASM rose by 11.3%, primarily due to reduced scheduled service capacity [5][10] - Total operating expenses increased by 2.2% year-over-year, reflecting the impact of rising landing fees and airport rent [10][11] Balance Sheet and Liquidity - As of June 30, 2025, total liquidity stood at $207 million, with net debt at $431 million [12][13] - Cash and cash equivalents decreased to $37 million from $83.2 million in the previous year, indicating a need for careful cash management [12][32] Fleet and Future Outlook - The airline's fleet included 45 passenger aircraft and 19 cargo aircraft as of June 30, 2025, with plans to expand the cargo fleet further [14][30] - Guidance for the third quarter of 2025 anticipates total revenue between $250 million and $260 million, reflecting a modest growth outlook [15]

Core Insights - Aecon Group Inc. reported a significant increase in revenue and backlog, driven by strategic acquisitions and strong demand in the construction sector [2][21][10] Financial Performance - Revenue for Q2 2025 was $1,302 million, a 52% increase from $853.8 million in Q2 2024 [6][4] - Operating profit for Q2 2025 was $2.3 million, compared to an operating loss of $166.3 million in Q2 2024 [8][4] - Adjusted EBITDA for Q2 2025 was $41.1 million, with a margin of 3.2%, compared to a negative adjusted EBITDA of $153.5 million and a margin of -18.0% in Q2 2024 [6][7] - Loss attributable to shareholders decreased to $7.6 million (diluted loss per share of $0.12) from $123.9 million (diluted loss per share of $1.99) in the same period last year [6][4] Backlog and Contracts - Reported backlog at June 30, 2025, was $10,746 million, up from $6,186 million at the same time last year, marking the highest backlog in Aecon's history [10][6] - New contract awards in Q2 2025 totaled $2,351 million, compared to $766 million in Q2 2024 [10][6] Segment Performance - In the Construction segment, revenue for Q2 2025 was $1,298 million, a 52% increase from $851.5 million in Q2 2024, driven by growth in industrial, nuclear, civil, urban transportation, and utilities operations [13][12] - The Concessions segment reported revenue of $2 million for Q2 2025, unchanged from the previous year [18][16] Strategic Developments - Aecon is leading significant nuclear refurbishment projects and has commenced the execution phase of the Darlington New Nuclear Project [2][21] - The Oneida Energy Storage Project, the largest grid-scale battery energy storage facility in Canada, officially began operations [6][5] Outlook - Revenue in 2025 is expected to be stronger than in 2024, supported by a record backlog, solid demand for recurring revenue programs, and a robust bid pipeline [21][22] - The company anticipates continued growth in most construction sectors and is focused on strategic investments to enhance operational effectiveness [26][22]

Core Viewpoint - Larimar Therapeutics, Inc. has successfully closed a public offering of 21,562,500 shares at a price of $3.20 per share, raising gross proceeds of $69.0 million before expenses [1][2]. Group 1: Offering Details - The offering included the full exercise of the underwriters' option to purchase an additional 2,812,500 shares [1]. - The shares were offered under a shelf registration statement declared effective by the SEC on May 24, 2024 [3]. Group 2: Use of Proceeds - The net proceeds from the offering will be utilized to support the development of nomlabofusp and other pipeline candidates, as well as for working capital and general corporate purposes, including research and development and pre-commercialization expenses [2]. Group 3: Company Overview - Larimar Therapeutics is a clinical-stage biotechnology company focused on developing treatments for complex rare diseases, with its lead compound nomlabofusp aimed at treating Friedreich's ataxia [5]. - The company plans to leverage its intracellular delivery platform to design additional fusion proteins targeting other rare diseases characterized by deficiencies in intracellular bioactive compounds [5].

Company Announcement - Ready Capital Corporation will release its second quarter 2025 financial results after the New York Stock Exchange closes on August 7, 2025 [1] - Management will host a webcast and conference call on August 8, 2025, at 8:30 a.m. Eastern Time to provide a business update and discuss the financial results for the quarter ended June 30, 2025 [1] Webcast and Dial-in Information - The company encourages the use of the webcast due to potential extended wait times for the conference call via dial-in, with the webcast available in the Investor Relations section of the company's website [2] - The conference call can be accessed by dialing 877-407-0792 for domestic calls or 201-689-8263 for international calls [3] Replay Information - A replay of the call will be available on the company's website approximately two hours after the live call and will remain accessible through August 22, 2025 [4] - To access the replay, the domestic dial-in number is 844-512-2921 and the international number is 412-317-6671, with a replay pin number of 13753253 [4] Company Overview - Ready Capital Corporation is a multi-strategy real estate finance company that originates, acquires, finances, and services investor and owner-occupied commercial real estate loans [5] - The company specializes in loans backed by commercial real estate, including agency multifamily, investor, construction, and bridge loans, as well as U.S. Small Business Administration loans under its Section 7(a) program [5] - Headquartered in New York, the company employs approximately 500 professionals nationwide [5]

Core Viewpoint - eXp World Holdings, Inc. continues to demonstrate resilience and growth in a dynamic real estate environment, driven by its agent-first model and commitment to innovation, with a focus on expanding its international business and enhancing the SUCCESS brand [2][8]. Financial Highlights - Revenue increased by 1% to $1.3 billion compared to the same period last year [8]. - The company reported a net loss of $(2.3) million, translating to a net loss per diluted share of $(0.01) [8]. - Total operating expenses rose to $1.31 billion from $1.28 billion, with adjusted operating costs increasing by 20% to $95.0 million [8]. - Adjusted EBITDA was reported at $11.2 million [8]. - Cash and cash equivalents totaled $94.6 million as of June 30, 2025, down from $108.4 million a year earlier [8]. - The company distributed $32.6 million to shareholders, including $24.9 million in common stock repurchases and $7.7 million in cash dividends [8]. Operational Highlights - eXp Realty has over 82,000 agents across 28 countries, making it the largest independent real estate brokerage globally [7]. - The global agent Net Promoter Score (aNPS) increased to 77, up from 76 in the prior-year period, indicating improved agent satisfaction [8]. - The number of agents and brokers on the eXp Realty platform decreased by 5% to 82,704 as of June 30, 2025 [8]. - Real estate sales transactions decreased by 2% to 118,612 in the second quarter of 2025, while real estate sales volume increased by 1% to $52.5 billion [8]. Strategic Focus - The company is committed to enhancing the agent value stack and ongoing programs like the co-sponsor initiative to attract top agents and teams [2]. - Glenn Sanford, the Founder and CEO, is shifting focus to SUCCESS® Enterprises to expand its brand and drive value for agents and shareholders [2].

Core Insights - Healthcare Realty Trust reported a GAAP net loss of $157.9 million, or $0.45 per share, for Q2 2025, compared to a loss of $143.8 million, or $0.39 per share, in Q2 2024 [3][5] - The company achieved NAREIT FFO of $120.4 million, or $0.34 per share, and Normalized FFO of $143.7 million, or $0.41 per share, showing slight improvements year-over-year [3][5] - The company executed 341 new and renewal leases totaling 1.5 million square feet during the quarter, with a 5.1% growth in cash NOI and a 90% occupancy rate [4][5] Financial Performance - The company’s total revenues for Q2 2025 were $297.5 million, slightly down from $298.9 million in Q1 2025 [29] - Property operating expenses were $109.9 million, while general and administrative expenses increased to $23.5 million [29] - The company reported a total asset value of $10.2 billion as of Q2 2025, down from $10.5 billion in Q1 2025 [26] Leasing Activity - The weighted average lease term for new leases was 5.3 years, with an average annual escalator of 3.2% [6] - Health system leasing constituted approximately 33% of the signed lease volume in the quarter [6] - Significant new leases included a 24,000 square foot lease with CLS Health in Houston and a 23,000 square foot lease with UC Irvine Health in California [6] Disposition and Debt Management - The company completed asset sales totaling $182.4 million through nine transactions in Q2 2025, contributing to a year-to-date total of $210.5 million at a blended cap rate of 6.2% [7][8] - The run-rate Net Debt to Adjusted EBITDA ratio improved to 6.0x, with expectations to decrease to between 5.4x and 5.7x by year-end [7][8] - A $1.5 billion revolving credit facility was extended to mature in July 2030, with additional extension options on outstanding term loans [8] Strategic Initiatives - The company announced a series of leadership changes, including the appointment of Peter Scott as President and CEO, and initiated a platform restructuring to enhance operational performance [10][12] - A Strategic Plan was published to outline actions aimed at maximizing shareholder value and improving operational performance [9] - The Board approved a common stock dividend of $0.24 per share, representing a 23% reduction from the previous level [13][14] Guidance - The company increased its Normalized FFO per share guidance to a range of $1.57 to $1.61 and adjusted Same Store Cash NOI growth guidance to 3.25% - 4.00% [15] - The updated guidance reflects the company's outlook on rental rates, occupancy levels, and operating expenses [15]

Core Viewpoint - Clarus Corporation reported a decline in sales and an increase in net loss for the second quarter of 2025, while emphasizing a strategic focus on operational execution and simplification of its product portfolio to drive future growth [3][4][8]. Financial Performance - Total sales for Q2 2025 were $55.2 million, down from $56.5 million in Q2 2024 [4][8]. - Sales in the Outdoor segment increased by 1% to $36.7 million, while the Adventure segment saw an 8% decrease to $18.6 million [4][5]. - Gross margin decreased to 35.6% from 36.1% year-over-year, primarily due to lower volumes and an unfavorable product mix in the Adventure segment [6][8]. - Selling, general and administrative expenses decreased to $26.9 million from $28.1 million, attributed to lower employee-related expenses and marketing costs [7][8]. Net Loss and Adjusted Metrics - The net loss for Q2 2025 was $8.4 million, or $(0.22) per diluted share, compared to a net loss of $5.5 million, or $(0.14) per diluted share in the prior year [8][9]. - Adjusted net loss was $1.1 million, or $(0.03) per diluted share, compared to an adjusted net loss of $1.2 million, or $(0.03) per diluted share in Q2 2024 [10][8]. - Adjusted EBITDA for the quarter was $(2.1) million, with an adjusted EBITDA margin of (3.8)%, compared to $(1.9) million and (3.4)% in the same quarter last year [11][8]. Cash Flow and Liquidity - Net cash used in operating activities was $(9.4) million, compared to net cash generated of $0.8 million in the prior year [12]. - Cash and cash equivalents totaled $28.5 million, down from $45.4 million at the end of 2024 [17]. Strategic Actions - The company completed the divestiture of its PIEPS snow safety brand for approximately $9.1 million, reflecting a focus on simplifying the Black Diamond business [13]. - Management is committed to prioritizing high-return initiatives to improve market responsiveness and product offerings [3].

Core Insights - Comstock Inc. will host a webinar on August 14, 2025, at 4:30 PM ET to discuss recent financial results and business updates [1][2] - The webinar will include a Q&A session for investors and interested parties [2] - Comstock Inc. focuses on clean energy technologies, extracting and converting under-utilized natural resources into reusable electrification metals [3] Company Overview - Comstock Inc. is listed on NYSE under the ticker LODE [3] - The company specializes in the commercialization of technologies that support clean energy systems [3] - Key products include silver, aluminum, copper, and other critical minerals sourced from end-of-life photovoltaics [3] Communication Strategy - Comstock Inc. utilizes its investor relations website and social media platforms for disclosing material non-public information [4]